You are here: Home » PTI Stories » National » News
Business Standard

Panacea Biotec shares soar nearly 12% after sales push

Press Trust of India  |  New Delhi 

of today soared nearly 12 per cent after the company said it has expanded its existing collaboration with Canada's Apotex Inc for sales and distribution of Prasugrel tablets in the US.

The stock zoomed 11.95 per cent to settle at Rs 245.90 on the Intra-day, it jumped 15.63 per cent to Rs 254.

At the NSE, it surged 10.91 per cent to close at Rs 245.35.

The company's market valuation also went up by Rs 161.16 crore to Rs 1,506.16 crore.

In terms of volume, 1.91 lakh of the company were traded on the and over 12 lakh changed hands at the during the day.

said Prasugrel has annual sales of USD 600 million in the US and is indicated for reduction of thrombotic cardiovascular events in people with acute coronary syndrome.

"has expanded its existing collaboration with Apotex Inc, the largest Canadian-owned pharmaceutical company, for sales and distribution of Prasugrel 5mg and 10mg tablets (generic version of Eli Lilly's Effient) in the US," the company said in a filing.

It further said: "The company has signed an exclusive licence and supply agreement with Apotex for this purpose. Under the terms of the agreement, Apotex shall be responsible for sales and distribution of the product in the USA and the company shall be responsible for manufacturing and supply".

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, September 11 2017. 18:32 IST